Monitoring the retention of a protein antigen in complete Freund's adjuvant, Alum, and Pluronic F-127 gel formulations by X-ray fluorescence

Pharmaceutical Development and Technology

Volumn 6, Issue 2, 2001, Pages 241-246

  MacLean, Donald S ^a,b   Robertson, J David ^c   Jay, Michael ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d University of Kentucky   (United States)

Author keywords

Adjuvant; Analysis; Protein; Retention; X ray Fluorescence(XRF)

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; BOVINE SERUM ALBUMIN; BUFFER; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; IODINATED BOVINE SERUM ALBUMIN; IODINE DERIVATIVE; POLOXAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; DRUG FORMULATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG RETENTION; FEMALE; GEL; INJECTION SITE; IODINATION; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; X RAY FLUORESCENCE;

ALUM COMPOUNDS; ANIMALS; ANTIGENS; CHEMISTRY, PHARMACEUTICAL; FEMALE; FREUND'S ADJUVANT; POLOXAMER; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, X-RAY EMISSION;

EID: 0035006095     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-100002200     Document Type: Article

References (23)

1. The effect of adjuvant on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine
2. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: A possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes
3. Hemopoietic growth and inhibitory factors in treatment of malignancies. A review
4. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review
5. Alpha interferon: The potential drug of adjuvant therapy: Past achievements and future challenges
6. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide
7. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity
8. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers
9. Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood IN VITRO
10. Fibronectin-pluronic coadsorption on a polystyrene surface with increasing hydrophobicity: Relationship to cell adhesion
11. Evaluation of pluronic F-127 based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model
12. A novel system based on a poloxamer/PGLA blend as a tetanus toxoid delivery vehicle
13. Ultrasonic activated drug delivery from pluronic P-105 micelles
14. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly (ethylene oxide)-poly(propylene oxide) copolymers
15. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats
16. Mechanisms of action of nonionic block copolymer adjuvant
17. The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes
18. Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigen
19. Adjuvant activity of saponin: Antigen localization studies
20. Adjuvant actions of polyclonal lymphocyte activators, IV Augmentation of antigen retention occurring early and transiently at the site of injection and in the draining lymph node
21. Non-invasive in vivo percutaneous absorption measurements using X-ray fluorescence
22. Secondary X-ray fluorescence for in vivo transdermal absorption measurements
23. Non-invasive measurement of protein release from subcutaneous Depo formulations in vivo using X-ray fluorescence